RXO, Inc.
RXO
$24.37
$0.010.04%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.43B | 1.47B | 1.42B | 1.42B | 1.43B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.43B | 1.47B | 1.42B | 1.42B | 1.43B |
| Cost of Revenue | 1.22B | 1.25B | 1.19B | 1.17B | 1.20B |
| Gross Profit | 204.00M | 219.00M | 236.00M | 254.00M | 232.00M |
| SG&A Expenses | 197.00M | 200.00M | 208.00M | 214.00M | 210.00M |
| Depreciation & Amortization | 26.00M | 28.00M | 26.00M | 30.00M | 32.00M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.44B | 1.48B | 1.42B | 1.41B | 1.44B |
| Operating Income | -19.00M | -9.00M | 2.00M | 10.00M | -10.00M |
| Income Before Tax | -49.00M | -51.00M | -15.00M | -10.00M | -39.00M |
| Income Tax Expenses | -13.00M | -5.00M | -1.00M | -1.00M | -8.00M |
| Earnings from Continuing Operations | -36.00M | -46.00M | -14.00M | -9.00M | -31.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -36.00M | -46.00M | -14.00M | -9.00M | -31.00M |
| EBIT | -19.00M | -9.00M | 2.00M | 10.00M | -10.00M |
| EBITDA | 7.00M | 19.00M | 28.00M | 40.00M | 22.00M |
| EPS Basic | -0.21 | -0.27 | -0.08 | -0.05 | -0.18 |
| Normalized Basic EPS | -0.11 | -0.07 | -0.03 | 0.00 | -0.07 |
| EPS Diluted | -0.21 | -0.27 | -0.08 | -0.05 | -0.18 |
| Normalized Diluted EPS | -0.11 | -0.07 | -0.03 | 0.00 | -0.07 |
| Average Basic Shares Outstanding | 169.10M | 168.72M | 168.58M | 168.53M | 168.02M |
| Average Diluted Shares Outstanding | 169.10M | 168.72M | 168.58M | 168.53M | 168.02M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |